LINC01010: A Potential Drug Target Or Biomarker (G154092)

Target Name: LINC01010

NCBI ID: G154092

LINC01010

Other Name(s): Long intergenic non-protein coding RNA 1010, transcript variant 1 | long intergenic non-protein coding RNA 1010

LINC01010: A Potential Drug Target Or Biomarker

LINC01010 is a non-protein coding RNA molecule that has been identified as a potential drug target or biomarker. It is a long intergenic non-protein coding RNA (lncRNA), which means it is not a protein but rather a RNA molecule that is transcribed from a gene that is located between the intron and the exon of another RNA molecule.

LINC01010 is a highly conserved lncRNA that is found in many different organisms, including humans. It is expressed in a variety of tissues and cells, including the brain, heart, and gastrointestinal tract. It has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation.

One of the key features of LINC01010 is its unique structure. It is a long RNA molecule that is primarily composed of a single exon. The exon is derived from the intron, which is a region of the RNA molecule that is transcribed from DNA. The exon is surrounded by a UTR (untranslated region) that is typically involved in the regulation of gene expression.

The conservation of LINC01010 across different organisms suggests that it is a highly conserved gene, which means that it is likely to be involved in a variety of cellular processes that are relevant to many different organisms. This makes it an attractive target for drug development or research into new biomarkers.

In addition to its conserved structure, LINC01010 has also been shown to play a role in the regulation of various cellular processes. For example, studies have shown that LINC01010 is involved in the regulation of cell growth, cell division, and cell apoptosis (programmed cell death). It is also involved in the regulation of angiogenesis (the formation of new blood vessels), which is important for the development and maintenance of tissues and organs.

In addition to its role in cellular processes, LINC01010 has also been shown to be involved in the regulation of gene expression. Studies have shown that LINC01010 can interact with various transcription factors, including NF-kappa-B (nuclear factor kappa B), to regulate the expression of target genes. This suggests that LINC01010 may be a useful biomarker or drug target for diseases that are characterized by disruptions in gene expression.

Given its conserved structure and its involvement in cellular processes, LINC01010 is an attractive target for drug development or research into new biomarkers. Further studies are needed to fully understand its role in these processes and to determine its potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1010

The "LINC01010 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01010 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets